In the field of myelodysplastic syndromes (MDS), there are a number of investigational studies designed with the hope of ...

verifying the treatment's success while showing it comes with a significant risk of a cancer-causing disorder – ...

Amer Zeidan, MBBS, discusses how ring sideroblasts status affects using luspatercept in patients with myelodysplastic ...

NIH clinical trial will test precision medicine treatments for myeloid cancers: Bethesda, Maryland Monday, October 28, 2024, 11:00 Hrs [IST] The National Institutes of Health (NIH ...

With my myelodysplastic syndrome and age, I find it hard to keep up; however, cancer and fatigue have taught me to live at my own pace.

“This approach opens new therapeutic avenues by attacking cancer’s altered metabolism, offering hope for more effective treatments.” By combining CB-839 with azacytidine, a drug that kills rapidly ...

DENVER — Retired pediatrician Max Elliott was used to taking care of his patients, but during the pandemic, when he was diagnosed with a rare blood cancer, he learned he needed specialized care.

RYTELO™ (imetelstat) is FDA approved for the treatment of low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent ...

A man who was diagnosed with cancer aged 15 and then again aged 18 is raising awareness of symptoms in young people. Charlie ...

Geron Corporation ( (GERN) ) has released its Q3 earnings. Here is a breakdown of the information Geron Corporation presented to its investors.